Detoxification of Electrophilic Chemical Threat Agents by Nucleophilic Scavengers
亲核清除剂对亲电化学威胁剂的解毒
基本信息
- 批准号:7294242
- 负责人:
- 金额:$ 54.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-30 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:2-chloroethyl ethyl sulfide7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideAntidotesApoptosisApoptoticAreaBiological MarkersBullaCarcinogensCell DeathCell NucleusCellsChemical AgentsChemicalsClassDNA AdductsDataDrug Metabolic DetoxicationEdemaEllagic AcidEnd PointEngineeringEnhancersEnzymesEpidemiologic StudiesEventFibrosisGenesGeneticGenetic Predisposition to DiseaseGenotypeGlutathioneGlutathione S-TransferaseGoalsHistopathologyHumanHuman ResourcesIn VitroIndividualInfiltrationInflammationKnowledgeLeadLeftLungLymphocyteMeasurementMeasuresMechlorethamineMedicalMelphalanMethodologyMethodsModelingMusMustardMustard AgentMustard GasMutagenesisMutationNecrosisNucleic AcidsOrganismPopulationPredispositionPreventionProcessProtective AgentsProteinsReactionReporterReporter GenesResearchResearch PersonnelRoleSamplingSignal PathwaySiteSkinStructure of parenchyma of lungSulfurTestingTherapeutic InterventionThinkingTissue ModelTissuesToxic effectTransgenic OrganismsTranslationsValidationVariantWorkadductairway epitheliumcarcinogenesischemical carcinogenchemical carcinogenesischemical reactionconceptcytotoxicitydesigndimethyl sulfateemergency service responderhuman tissuein vivomacromoleculemouse modelmultidisciplinarynovelpreventprogramsrepairedresearch studyresponsetoxicant
项目摘要
DESCRIPTION (provided by applicant): One class of chemical threat agents for which medical countermeasures must be developed, the sulfur and nitrogen mustards (SNMs), exert their toxic effects through chemical reactions that involve an electrophilic intermediate. In this respect they are similar to many widely studied chemical carcinogens, and therefore strategies that have been used to detoxify these carcinogens should be applicable to the mustard agents. The primary strategies to be developed in this Project will block the ability of SNMs to form DNA adducts in exposed cells. We will use a combined in vitro/in vivo approach to determine the efficacy of two groups of potential protective agents: nucleophilic scavenging agents and agents that enhance endogenous conjugation reactions, particularly the addition of glutathione to the electrophile by the glutathione-S transferase (GST) enzymes. Two classes of nucleophilic scavenger will be tested: the dithiopurines (DTP) and ellagic acid. Both of these have been shown to completely detoxify the carcinogen BPDE. DTP has also been shown to detoxify melphalan, a nitrogen mustard, and in preliminary studies we have demonstrated facile reaction of DTP with a sulfur mustard, 2-chloroethyl ethyl sulfide. We will use cultured human cells derived from skin and lung to first test these protective compounds against SNMs, with cytotoxicity and mutagenesis as the primary endpoints. The most efficacious compounds will then be tested in two engineered human tissue models, one representing skin, the other representing airway epithelia, with toxic histopathology as the primary endpoint. Finally, the effective compounds will be tested in vivo in mice, using either topical treatment with subsequent analysis of skin, or intratracheal instillation with subsequent analysis of lung tissue. Toxicity endpoints in the mouse tissues will include histopathology (pyknotic/apoptotic nuclei, edema, vesication, infiltration, fibrosis) and induction of mutations in reporter genes carried in the transgenic mutation-reporter mice. These experiments will test the best scavenger, the best GSH/GST enhancer, and a combination of the two compounds. We will also test the sensitivity of human lymphocytes from 300 individuals to SNMs, and correlate the sensitivity with genotypes measured at several GST genetic loci that are polymorphic in the human population. Other biomarkers of exposure, including generalized protein adducts and a specific protein adduct will be analyzed where appropriate. Relevance: We expect to validate a strategy to efficiently detoxify electrophilic chemical threat agents, such as the SNMs and dimethyl sulfate. This will allow us to begin to formulate novel antidotes that could be used to protect personnel responding to an incident involving SNMs, and to stabilize exposed individuals against further damage. In addition, we will obtain data that indicates whether or not individuals with variants of a particular class of genes, the GSTs, are more susceptible to the effects of SNM toxicants.
描述(由申请人提供):一类必须开发医疗对策的化学威胁剂,硫和氮芥菜(SNMs),通过涉及亲电中间体的化学反应发挥其毒性作用。在这方面,它们与许多被广泛研究的化学致癌物相似,因此,用于解毒这些致癌物的策略应该适用于芥菜剂。在这个项目中开发的主要策略将阻止SNMs在暴露的细胞中形成DNA加合物的能力。我们将使用体外/体内联合方法来确定两组潜在保护剂的功效:亲核清除剂和增强内源性偶联反应的剂,特别是通过谷胱甘肽- s转移酶(GST)将谷胱甘肽添加到亲电试剂上的剂。两类亲核清除剂将被测试:二硫嘌呤(DTP)和鞣花酸。这两种方法都被证明可以完全解毒致癌物质BPDE。DTP还被证明可以解毒melphalan,一种氮芥菜,在初步研究中,我们已经证明DTP与硫芥菜,2-氯乙基乙基硫化物容易反应。我们将使用来自皮肤和肺的培养人类细胞,以细胞毒性和诱变作为主要终点,首先测试这些保护化合物对SNMs的作用。最有效的化合物将在两种工程人体组织模型中进行测试,一种代表皮肤,另一种代表气道上皮,以毒性组织病理学为主要终点。最后,有效的化合物将在小鼠体内进行测试,使用局部治疗和随后的皮肤分析,或气管内灌注和随后的肺组织分析。小鼠组织中的毒性终点将包括组织病理学(核收缩/凋亡、水肿、囊泡、浸润、纤维化)和诱导转基因突变报告小鼠携带的报告基因突变。这些实验将测试最佳清除剂,最佳GSH/GST增强剂,以及两种化合物的组合。我们还将测试来自300个个体的人类淋巴细胞对SNMs的敏感性,并将敏感性与在人类群体中多态性的几个GST遗传位点测量的基因型相关联。其他暴露的生物标志物,包括广义蛋白质加合物和特定蛋白质加合物,将在适当的时候进行分析。相关性:我们期望验证一种有效解毒亲电化学威胁剂的策略,如SNMs和硫酸二甲酯。这将使我们能够开始制定新的解毒剂,可用于保护人员应对涉及snm的事件,并稳定暴露的个人免受进一步的伤害。此外,我们将获得数据,以表明具有特定类型基因(gst)变体的个体是否更容易受到SNM毒物的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael C MacLeod其他文献
Michael C MacLeod的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael C MacLeod', 18)}}的其他基金
Detoxification of Electrophilic Chemical Threat Agents by Nucleophilic Scavengers
亲核清除剂对亲电化学威胁剂的解毒
- 批准号:
7224542 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Mechanisms of ATF3-induced mammary tumorigenesis
ATF3诱导乳腺肿瘤发生的机制
- 批准号:
7738885 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Detoxification of Electrophilic Chemical Threat Agents by Nucleophilic Scavengers
亲核清除剂对亲电化学威胁剂的解毒
- 批准号:
7665443 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Mechanisms of ATF3-induced mammary tumorigenesis
ATF3诱导乳腺肿瘤发生的机制
- 批准号:
7210219 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Mechanisms of ATF3-induced mammary tumorigenesis
ATF3诱导乳腺肿瘤发生的机制
- 批准号:
7996640 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Detoxification of Electrophilic Chemical Threat Agents by Nucleophilic Scavengers
亲核清除剂对亲电化学威胁剂的解毒
- 批准号:
7906825 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Mechanisms of ATF3-induced mammary tumorigenesis
ATF3诱导乳腺肿瘤发生的机制
- 批准号:
7534043 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Mechanisms of ATF3-induced mammary tumorigenesis
ATF3诱导乳腺肿瘤发生的机制
- 批准号:
7325780 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Detoxification of Electrophilic Chemical Threat Agents by Nucleophilic Scavengers
亲核清除剂对亲电化学威胁剂的解毒
- 批准号:
7473988 - 财政年份:2006
- 资助金额:
$ 54.62万 - 项目类别:
Construction of gene expression signatures with RAGE
使用 RAGE 构建基因表达特征
- 批准号:
6585975 - 财政年份:2002
- 资助金额:
$ 54.62万 - 项目类别: